Company: MGLD
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001493152-25-009595
Chunk: 18

Company: Marygold Companies, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 18
---
 contemplated by the Equity Distribution Agreement in an amount not to exceed $25,000 in the aggregate in addition to up to $2,500 quarterly for Maxim’s counsel’s fees and any incidental expenses to be reimbursed by us.

We estimate that the total expenses for this offering, excluding the commissions payable as compensation to Maxim, will be approximately $80,500. The remaining sales proceeds after deducting any expenses payable by us and any transaction fees imposed by any governmental, regulatory, or self-regulatory organization in connection with the sales, will equal our net proceeds for the sale of such shares of common stock.

| S-15 |

There are no minimum sale requirements as a condition to this offering. Accordingly, the actual total public offering price, commissions and net proceeds to us, if any, are not determinable at this time. The actual dollar amount and number of shares of common stock we will sell pursuant to this prospectus supplement and the accompanying prospectus will depend, among other things, on market conditions and our capital raising requirements. Maxim is not required to sell any certain number of shares or dollar amount of our common stock, but Maxim will use its commercially reasonable efforts consistent with its normal trading and sales practices to sell on our behalf all of the shares of common stock requested to be sold by us, subject to the conditions set forth in the Equity Distribution Agreement.

In connection with the sales of our common stock on our behalf, Maxim will be deemed to be an “underwriter”within the meaning of the Securities Act, and the compensation paid to Maxim will be deemed to be underwriting commissions or discounts.

Maxim will not engage in any market making activities involving shares of our common stock while the offering is ongoing under this prospectus if such activity would be prohibited under Regulation M or other anti-manipulation rules under the Securities Act. As our sales agent, the Sales Agent will not engage in any transactions that stabilizes shares of our common stock.

To the extent any sales are made, we will report at least quarterly the number of shares of common stock sold through Maxim under the Equity Distribution Agreement, the net proceeds to us and the compensation paid by us to Maxim in connection with the sales of common stock.

In the event we sell shares to Maxim as principal, we will enter into a separate terms sheet or agreement with Maxim with regard thereto.

The offering of our shares of common stock pursuant to the Equity Distribution Agreement will terminate upon the earlier of (i) the sale of all of our shares of common stock subject to the Equity Distribution Agreement or